Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 19.92M | $776.0M | 31.70% | -- | 2026-06-30 |
| BlackRock, Inc. | 4.14M | $161.0M | 6.58% | +200.1K | 2026-06-30 |
| Price T Rowe Associates Inc | 3.25M | $126.0M | 5.17% | +1.21M | 2026-06-30 |
| State Street Corp | 2.42M | $94.0M | 3.85% | +168.5K | 2026-06-30 |
| Goldman Sachs Group Inc | 2.32M | $90.0M | 3.69% | +577.0K | 2026-06-30 |
| Vanguard Capital Management LLC | 1.80M | $70.0M | 2.87% | +87.6K | 2026-06-30 |
| Braidwell LP | 1.79M | $69.0M | 2.84% | -31.3K | 2026-06-30 |
| Jupiter Topco LLC | 1.53M | $59.0M | 2.43% | -- | 2026-06-30 |
| Rtw Investments, LP | 1.49M | $57.0M | 2.37% | -- | 2026-06-30 |
| Boxer Capital Management, LLC | 1.48M | $57.0M | 2.35% | +116.6K | 2026-06-30 |
